Novartis has reported a 41 percent drop in operating income...

Novartis has reported a 41 percent drop in operating income to $150 million for its eyewear business unit, Alcon, in the second quarter, as a $119 million charge for impairment of intangible assets aggravated a drop in the core operating margin of 5.5 percentage points to 31.1 percent of sales. ...

Already an Eyewear Intelligence subscriber? Sign in here.

barrier_image_OIC

Subscribe today

Buying a membership today will give you:

  • Unlimited access to ewintelligence.com - all insight and analysis available online
  • Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
  • Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
  • Case studies and best practices on business challenges
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
  • Access to over 11,500 articles and analyses in the archive
  • Personal library to save articles and track your key content
  • Powerful search and intuitive navigation
  • Organisation-wide access across offices, people and devices

To continue reading this article register now.